- Report
- November 2023
- 172 Pages
Global
From €3193EUR$3,599USD£2,787GBP
- Report
- May 2023
- 160 Pages
Global
From €4391EUR$4,949USD£3,833GBP
- Report
- April 2023
- 147 Pages
Global
From €4391EUR$4,949USD£3,833GBP
- Report
- March 2023
- 147 Pages
Global
From €4391EUR$4,949USD£3,833GBP
- Report
- December 2023
- 117 Pages
Global
From €13303EUR$14,995USD£11,612GBP
- Report
- October 2022
- 292 Pages
Global
From €2218EUR$2,500USD£1,936GBP
- Report
- July 2024
Global
From €3416EUR$3,850USD£2,981GBP
€4303EUR$4,850USD£3,756GBP
- Report
- March 2024
- 132 Pages
Africa, Middle East
From €1331EUR$1,500USD£1,162GBP
- Report
- March 2025
- 100 Pages
China
From €1597EUR$1,800USD£1,394GBP
- Report
- March 2025
- 55 Pages
China
From €1597EUR$1,800USD£1,394GBP
- Report
- December 2022
Global
€4214EUR$4,750USD£3,678GBP
- Report
- March 2019
- 17 Pages
Global
€8872EUR$10,000USD£7,744GBP
- Report
- March 2019
- 17 Pages
Global
€8872EUR$10,000USD£7,744GBP
- Report
- May 2022
- 843 Pages
Global
From €2218EUR$2,500USD£1,936GBP
- Report
- August 2025
- 99 Pages
Global
From €3500EUR$4,226USD£3,162GBP
- Report
- November 2024
- 86 Pages
Global
From €3500EUR$4,226USD£3,162GBP
- Report
- October 2024
- 85 Pages
Global
From €3500EUR$4,226USD£3,162GBP
- Report
- February 2024
- 92 Pages
Global
From €3500EUR$4,226USD£3,162GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$4,226USD£3,162GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$4,226USD£3,162GBP

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more